| Joshua Marshall Beckman, MD | |
|
7780 S Broadway Ste 350, Littleton, CO 80122-2641 | |
| (720) 638-7500 | |
| (720) 583-6770 |
| Full Name | Joshua Marshall Beckman |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 14 Years |
| Location | 7780 S Broadway Ste 350, Littleton, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558686113 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centura Health-st Anthony Hospital | Lakewood, CO | Hospital |
| Orthocolorado Hospital At St Anthony Med Campus | Lakewood, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings are a first step toward finding ways to prevent this serious and potentially life-threatening treatment-related complication.
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.
Motivational interviewing may help specific subgroups of patients with schizophrenia to adhere to their antipsychotic medication, a study suggests.
"Despite a federal law requiring hospitals and doctors to release medical records to patients who ask for them, patients are reporting they have a hard time accessing" those records and that can lead to serious complications.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings are a first step toward finding ways to prevent this serious and potentially life-threatening treatment-related complication.
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.
Motivational interviewing may help specific subgroups of patients with schizophrenia to adhere to their antipsychotic medication, a study suggests.
"Despite a federal law requiring hospitals and doctors to release medical records to patients who ask for them, patients are reporting they have a hard time accessing" those records and that can lead to serious complications.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Entity Name | Banner Health Physicians Colorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073899134 PECOS PAC ID: 8921273038 Enrollment ID: O20111219000237 |
News Archive
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings are a first step toward finding ways to prevent this serious and potentially life-threatening treatment-related complication.
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.
Motivational interviewing may help specific subgroups of patients with schizophrenia to adhere to their antipsychotic medication, a study suggests.
"Despite a federal law requiring hospitals and doctors to release medical records to patients who ask for them, patients are reporting they have a hard time accessing" those records and that can lead to serious complications.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Entity Name | Neurosurgery One Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255681615 PECOS PAC ID: 8022269612 Enrollment ID: O20121107000531 |
News Archive
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings are a first step toward finding ways to prevent this serious and potentially life-threatening treatment-related complication.
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.
Motivational interviewing may help specific subgroups of patients with schizophrenia to adhere to their antipsychotic medication, a study suggests.
"Despite a federal law requiring hospitals and doctors to release medical records to patients who ask for them, patients are reporting they have a hard time accessing" those records and that can lead to serious complications.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Marshall Beckman, MD Po Box 5693, Denver, CO 80217-5693 Ph: (303) 306-7783 | Joshua Marshall Beckman, MD 7780 S Broadway Ste 350, Littleton, CO 80122-2641 Ph: (720) 638-7500 |
News Archive
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings are a first step toward finding ways to prevent this serious and potentially life-threatening treatment-related complication.
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.
Motivational interviewing may help specific subgroups of patients with schizophrenia to adhere to their antipsychotic medication, a study suggests.
"Despite a federal law requiring hospitals and doctors to release medical records to patients who ask for them, patients are reporting they have a hard time accessing" those records and that can lead to serious complications.
CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced today that the draft Clinical Study Report from CG400549's Phase I Multiple Ascending Dose Study has just been received.
› Verified 9 days ago
Dr. Paul D Boone, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 | |
Dr. Wissam Asfahani, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 | |
Abhijeet Gummadavelli, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 | |
Mrs. Jennifer Rebecca Sousa, AGNP-C Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 | |
Dr. John Adair Prall, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway, Suite 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 303-649-7030 | |
Kelly L Mowrey, RN,MS, ANP-C, CNRN Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 | |
Dr. Adam P. Smith, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway, #350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |